APEX Research is a Munich-based independent contract research organization. Since 1994, we are conducting regulatory pharmaceutical studies on behalf of the pharmaceutical industry on our own 12-bed trial unit.
Our research focus is on pharmacokinetic studies examining the influence of impaired liver or kidney function on the metabolism and excretion of pharmaceuticals. Accordingly, we primarily work with patients suffering from compromised liver or kidney function, up to and including dialysis. In addition, we also conduct pharmaceutical studies with other patient groups (e.g. diabetes, hypertension, COPD). We are able to contribute our years of experience in the field of clinical research to each new project.